Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Bronchial Neoplasms × nazartinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Rectal Neoplasms 1 Noonan Syndrome 1 Neoplasms 1 Melanoma 1 Lung Neoplasms 1 Intestinal Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 EGFR-mutant Non-small Cell Lung Cancer 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Ductal 1 Bronchial Neoplasms 1 Breast Neoplasms 1 Adenocarcinoma of Lung 1 Adenocarcinoma 1

Interventions

entinostat 3 osimertinib 2 Pemetrexed 2 Carboplatin 2 trametinib 1 pembrolizumab 1 nazartinib 1 exemestane 1 Erlotinib Hydrochloride 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03516214 2024-02-15

EATON

University of Cologne

Phase 1 Completed

Bronchial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡